Search results
Showing results for
Neutralising mAbs, a form of anti-viral medicine, are being explored as an attractive option to treat symptoms of COVID-19 and in some cases prevent infection. But what are the pros and cons of this type of treatment and what should regulators consider before granting approval?
Kadoorie Institute for Trauma, Emergency and Critical Care
The Kadoorie Institute designs and tests innovative treatments and care pathways that improve patient outcomes and deliver more efficient healthcare. By combining resources and expertise across Trauma, Emergency and Critical Care, the Institute accelerates this research.
OxKen
The Oxford Kennedy MB PhD (BM DPhil) Educational Training Program